203 related articles for article (PubMed ID: 10438369)
1. Differential susceptibility of two species of macaques to experimental vaginal candidiasis.
Steele C; Ratterree M; Fidel PL
J Infect Dis; 1999 Sep; 180(3):802-10. PubMed ID: 10438369
[TBL] [Abstract][Full Text] [Related]
2. History and update on host defense against vaginal candidiasis.
Fidel PL
Am J Reprod Immunol; 2007 Jan; 57(1):2-12. PubMed ID: 17156186
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibition of Candida albicans by human vaginal epithelial cells.
Barousse MM; Steele C; Dunlap K; Espinosa T; Boikov D; Sobel JD; Fidel PL
J Infect Dis; 2001 Dec; 184(11):1489-93. PubMed ID: 11709796
[TBL] [Abstract][Full Text] [Related]
4. Innate differences between simian-human immunodeficiency virus (SHIV)(KU-2)-infected rhesus and pig-tailed macaques in development of neurological disease.
Buch SJ; Villinger F; Pinson D; Hou Y; Adany I; Li Z; Dalal R; Raghavan R; Kumar A; Narayan O
Virology; 2002 Mar; 295(1):54-62. PubMed ID: 12033765
[TBL] [Abstract][Full Text] [Related]
5. Persistent colonization and transient suppression of DTH responses in an estrogen-dependent vaginal candidosis murine model.
Hamad M; Abu-Elteen KH; Ghaleb M
New Microbiol; 2002 Jan; 25(1):65-73. PubMed ID: 11837393
[TBL] [Abstract][Full Text] [Related]
6. Vaginal candidiasis: review and role of local mucosal immunity.
Fidel PL
AIDS Patient Care STDS; 1998 May; 12(5):359-66. PubMed ID: 11361971
[TBL] [Abstract][Full Text] [Related]
7. Distinct protective host defenses against oral and vaginal candidiasis.
Fidel PL
Med Mycol; 2002 Aug; 40(4):359-75. PubMed ID: 12230215
[TBL] [Abstract][Full Text] [Related]
8. Candida-specific systemic cell-mediated immune reactivities in human immunodeficiency virus-positive persons with mucosal candidiasis.
Leigh JE; Barousse M; Swoboda RK; Myers T; Hager S; Wolf NA; Cutright JL; Thompson J; Sobel JD; Fidel PL
J Infect Dis; 2001 Jan; 183(2):277-285. PubMed ID: 11120933
[TBL] [Abstract][Full Text] [Related]
9. Vaginal eosinophils and IgE antibodies to Candida albicans in women with recurrent vaginitis.
Witkin SS; Jeremias J; Ledger WJ
J Med Vet Mycol; 1989; 27(1):57-8. PubMed ID: 2666634
[TBL] [Abstract][Full Text] [Related]
10. Candida-specific antibodies during experimental vaginal candidiasis in mice.
Wozniak KL; Wormley FL; Fidel PL
Infect Immun; 2002 Oct; 70(10):5790-9. PubMed ID: 12228309
[TBL] [Abstract][Full Text] [Related]
11. The protective immune response against vaginal candidiasis: lessons learned from clinical studies and animal models.
Fidel PL
Int Rev Immunol; 2002; 21(6):515-48. PubMed ID: 12650240
[TBL] [Abstract][Full Text] [Related]
12. Biased genotype distributions of Candida albicans strains associated with vulvovaginal candidosis and candidal balanoposthitis in China.
Li J; Fan SR; Liu XP; Li DM; Nie ZH; Li F; Lin H; Huang WM; Zong LL; Jin JG; Lei H; Bai FY
Clin Infect Dis; 2008 Nov; 47(9):1119-25. PubMed ID: 18808351
[TBL] [Abstract][Full Text] [Related]
13. Candida albicans-secreted aspartic proteinases modify the epithelial cytokine response in an in vitro model of vaginal candidiasis.
Schaller M; Korting HC; Borelli C; Hamm G; Hube B
Infect Immun; 2005 May; 73(5):2758-65. PubMed ID: 15845479
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence of Candida albicans and Candida non-albicans in clinical samples during 1999-2001].
Mujica MT; Finquelievich JL; Jewtuchowicz V; Iovannitti CA
Rev Argent Microbiol; 2004; 36(3):107-12. PubMed ID: 15559191
[TBL] [Abstract][Full Text] [Related]
15. IgA and IgG antibodies to Candida albicans in the genital tract secretions of women with or without vaginal candidosis.
Gough PM; Warnock DW; Richardson MD; Mansell NJ; King JM
Sabouraudia; 1984; 22(4):265-71. PubMed ID: 6390734
[TBL] [Abstract][Full Text] [Related]
16. Local immune responsiveness following intravaginal challenge with Candida antigen in adult women at different stages of the menstrual cycle.
Fidel PL; Barousse M; Lounev V; Espinosa T; Chesson RR; Dunlap K
Med Mycol; 2003 Apr; 41(2):97-109. PubMed ID: 12964841
[TBL] [Abstract][Full Text] [Related]
17. Genotype comparisons of strains of Candida albicans from patients with cutaneous candidiasis and vaginal candidiasis.
She XD; Wang XJ; Fu MH; Shen YN; Liu WD
Chin Med J (Engl); 2008 Aug; 121(15):1450-5. PubMed ID: 18959125
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
[TBL] [Abstract][Full Text] [Related]
19. Genetic analysis of innate immunity in resistance to Candida albicans.
Tuite A; Mullick A; Gros P
Genes Immun; 2004 Nov; 5(7):576-87. PubMed ID: 15372070
[TBL] [Abstract][Full Text] [Related]
20. Type 1 T helper cells specific for Candida albicans antigens in peripheral blood and vaginal mucosa of women with recurrent vaginal candidiasis.
Piccinni MP; Vultaggio A; Scaletti C; Livi C; Gomez MJ; Giudizi MG; Biagiotti R; Cassone A; Romagnani S; Maggi E
J Infect Dis; 2002 Jul; 186(1):87-93. PubMed ID: 12089666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
